Ocugen adjourns special meeting to Oct 5 on proposal to increase authorized shares by 250M

Ocugen, Inc.

Special meeting of Sept 21, 2026 adjourned to Oct 5, 2026, solely for Proposal 1 to increase authorized common stock by 250,000,000 shares.
Adjournment proposal (Proposal 2) approved: 124,584,658 for, 33,639,820 against, 1,989,953 abstaining.
160,214,431 shares represented (47.3% of outstanding) at meeting; quorum present.
Record date remains July 27, 2026 for adjourned meeting; stockholders who already voted need not take action.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.